| Quarter | Holdings | Value ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q3 2026 | Reported by Johnson & Johnson | 13F-NT | 10/26/2026 | 000090445426000543 | ||
| Q2 2026 | Reported by Johnson & Johnson | 13F-NT | 8/6/2026 | 000090445426000437 | ||
| Q1 2026 | Reported by Johnson & Johnson | 13F-NT | 5/13/2026 | 000090445426000278 | ||
| Q4 2025 | Reported by Johnson & Johnson | 13F-NT | 2/13/2026 | 000090445426000108 | ||
| Q3 2025 | Reported by Johnson & Johnson | 13F-NT | 11/13/2025 | 000090445425000589 | ||
| Q2 2025 | Reported by Johnson & Johnson | 13F-NT | 7/22/2025 | 000090445425000369 | ||
| Q1 2025 | Reported by Johnson & Johnson | 13F-NT | 5/7/2025 | 000090445425000240 | ||
| Q4 2024 | Reported by Johnson & Johnson | 13F-NT | 2/13/2025 | 000090445425000126 | ||
| Q3 2024 | Reported by Johnson & Johnson | 13F-NT | 11/13/2024 | 000090445424000606 | ||
| Q2 2024 | Reported by Johnson & Johnson | 13F-NT | 8/9/2024 | 000090445424000453 | ||
| Q1 2024 | Reported by Johnson & Johnson | 13F-NT | 5/10/2024 | 000090445424000287 | ||
| Q4 2023 | Reported by Johnson & Johnson | 13F-NT | 2/14/2024 | 000090445424000153 | ||
| Q2 2021 | 21 | 978,187 | FATE, ARWR, PTGX, CVRX | 13F-HR | 8/3/2021 | 000156761921014327 |
| Q1 2021 | 17 | 772,099 | FATE, ARWR, PTGX, LEGN | 13F-HR | 5/6/2021 | 000156761921009219 |
| Q4 2020 | 15 | 775,441 | FATE, ARWR, PTGX, LEGN | 13F-HR | 2/9/2021 | 000156761921002494 |
| Q3 2020 | 16 | 496,919 | ARWR, FATE, LEGN, PTGX | 13F-HR | 11/3/2020 | 000156761920018617 |
| Q2 2020 | 15 | 509,066 | ARWR, FATE, LEGN, FUSN | 13F-HR | 8/12/2020 | 000156761920014843 |
| Q1 2020 | 12 | 183,739 | ARWR, MGTX, PTGX, PHGE | 13F-HR | 5/13/2020 | 000156761920009803 |
| Q4 2019 | 11 | 277,314 | ARWR, PHGE, PTGX, PRVB | 13F-HR | 2/14/2020 | 000156761920003776 |
Investors who own more than 5% of a class must file a Schedule 13D or 13G.
1 security where the latest filing since 12/18/2024 is a 13G, filed 10/15/2026. View all